Cynthia Carlsson, MD, MS, and Sterling Johnson, PhD, recently joined Nathaniel Chin, MD, on a special episode of the Dementia Matters podcast highlighting details and findings from the lecanemab phase 3 clinical trials. Carlsson and Johnson answered questions about the trials’ primary and secondary outcomes and the medication’s safety profile. They also discussed who was represented in the study and what happens going forward following this accelerated approval.
Watch the video episode here: